-
Author Correction: High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial (Nature Medicine, (2023), 29, 3, (588-592), 10.1038/s41591-022-02199-y)
van Dorp, J., Pipinikas, C., Suelmann, B. B. M., Mehra, N., van Dijk, N., Marsico, G., van Montfoort, M. L., Hackinger, S., Braaf, L. M., Amarante, T., van Steenis, C., McLay, K., Daletzakis, A., van den Broek, D., van de Kamp, M. W., Hendricksen, K., de Feijter, J. M., Boellaard, T. N., Meijer, R. P. & van der Heijden, A. G. & 4 others, , Jan 2024, In: Nature Medicine. 30, 1, p. 304 1 p.Research output: Contribution to journal › Comment/Letter to the editor* › Academic
-
Long-term quality of life in patients with bladder cancer following radical cystectomy
Akdemir, E., Stuiver, M. M., van de Kamp, M. W., der Hulst, J. B. V., Mertens, L. S., Hendricksen, K., van Harten, W. H., May, A. M. & Sweegers, M. G., 2024, (E-pub ahead of print) In: BJU international.Research output: Contribution to journal › Article* › Academic › peer-review
-
Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy
Claps, F., van de Kamp, M. W., Mayr, R., Bostrom, P. J., Shariat, S. F., Hippe, K., Bertz, S., Neuzillet, Y., Sanders, J., Otto, W., van der Heijden, M. S., Jewett, M. A. S., Stöhr, R., Zlotta, A. R., Trombetta, C., Eckstein, M., Mertens, L. S., Burger, M., Soorojebally, Y. & Wullich, B. & 12 others, , Aug 2023, In: BJU International. 132, 2, p. 170-180 11 p.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
